Caribou Biosciences (CRBU) vs eXoZymes (EXOZ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
eXoZymes (EXOZ) has outperformed Caribou Biosciences (CRBU) over the past year, losing 59.0% versus a loss of 74.6%. Caribou Biosciences is the larger company by market cap ($51.6 million vs $49.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CRBU | EXOZ |
|---|---|---|
| Share price | $0.4812 | $5.27 |
| Market cap | $51.59M | $49.04M |
| 1-day change | -22.06% | -4.87% |
| YTD return | -61.17% | -49.17% |
| 1-year return | -74.59% | -58.96% |
| 5-year return | -97.04% | — |
| EPS (TTM) | $-1.08 | $-1.19 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.54 | $18.40 |
| 52-week low | $0.4503 | $4.35 |
| Distance from 52-week high | -86.39% | -71.36% |
| Average volume | 1.87M | 6.80K |
| Shares outstanding | 107.21M | 9.30M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EXOZ has outperformed CRBU by 15.6 percentage points over the past year.
CRBU vs EXOZ FAQ
Which is bigger, Caribou Biosciences or eXoZymes?
Caribou Biosciences (CRBU) is larger, with a market capitalization of $51.59M compared with $49.04M for eXoZymes (EXOZ).
Which stock has performed better over the past year, CRBU or EXOZ?
EXOZ returned -58.96% over the past 12 months, compared with -74.59% for CRBU (price return, excluding dividends). Past performance does not predict future results.
Are Caribou Biosciences and eXoZymes in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.